Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces ...

We would like most of the manufacturing to be centric in locations where it is most economic. Looking at every country's ...

Cipla has expanded capacity in the US and intends to manufacture such products,” the report stated. In the case of tariff barriers, “generics companies are likely to be more selective ...

a subsidiary of Cipla, on Wednesday said it has partnered with Swiggy, Zomato and Dunzo for home deliveries of over-the-counter wellness products in the wake of the nationwide lockdown.

The report highlighted the key factors contributing to Cipla's upward trajectory, emphasizing the company's strategic focus on complex products and the resultant impact on margins. The report ...

The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero.

MUMBAI/BENGALURU, Feb 28 (Reuters) - Tariffs should not influence decisions at Indian drug companies, Cipla's (CIPL.NS ... on exports of its pharmaceutical products into the U.S., according ...

Indian Pharmaceutical Alliance Pushes for Zero Import Duty on US Drugs to Strengthen Local Industry - The Indian Pharmaceutical Alliance (IPA), representing major drug manufacturers like Cipla , Dr.